Center for Congenital Heart Diseases, Department of Cardiothoracic Surgery, Beatrix Children's Hospital, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9700 RB, Groningen, The Netherlands.
Department of Genetics, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Eur J Pediatr. 2024 Nov 18;184(1):25. doi: 10.1007/s00431-024-05857-0.
The purpose of this study is to evaluate the diagnostic and therapeutic yield of a specialized clinic for children with suspicion of a hereditary thoracic aortic disease (HTAD), including Marfan Syndrome (MFS), and to investigate the diagnostic value of presenting symptoms and findings during evaluation. This retrospective observational study included all patients younger than 18 years old at initial referral between 1998 and 2018. Clinical data, medical treatment, surgical interventions, and clinical events during surveillance were collected until December 2023. A case-control comparison between patients with and without an eventual diagnosis of HTAD was performed using logistic regression analysis to investigate the diagnostic value of collected variables. A total of 355 children were referred and evaluated at the clinic, resulting in 89 new diagnoses, with a diagnostic yield of 21% HTAD, including 59 cases of MFS. Younger age at referral, ectopia lentis, aortic dilatation, and facial features were among the strongest predictors of MFS and other HTAD, while pectus excavatum and arm span-height ratio had no predictive value at childhood age. Of patients with MFS, 65% received antihypertensive medication, and 8% of patients with HTAD underwent prophylactic aortic surgery, in some cases even during childhood. Conclusion: Evaluation of children for HTAD in our specialized Marfan clinic resulted in a high diagnostic yield and subsequent therapeutic implications. Indeed, early recognition of symptoms and signs and referral to such a specialized clinic may lead to early diagnosis, surveillance, and timely treatment, thereby possibly limiting acute aortic events and even mortality.
本研究旨在评估一个专门针对遗传性胸主动脉疾病(HTAD)患儿的诊疗效果,包括马凡综合征(MFS),并探讨评估过程中表现症状和检查结果的诊断价值。这是一项回顾性观察性研究,纳入了 1998 年至 2018 年期间初次就诊时年龄小于 18 岁的所有患者。收集了临床数据、治疗方法、手术干预以及随访期间的临床事件,直至 2023 年 12 月。采用逻辑回归分析对有和无最终 HTAD 诊断的患者进行病例对照比较,以探讨所收集变量的诊断价值。共有 355 名儿童在该诊所接受了转介和评估,最终确诊 89 例 HTAD,其中 59 例为 MFS。转诊时年龄较小、晶状体异位、主动脉扩张和面部特征是 MFS 和其他 HTAD 的最强预测因素,而漏斗胸和臂展身高比在儿童时期没有预测价值。在 MFS 患者中,65%接受了降压药物治疗,8%的 HTAD 患者接受了预防性主动脉手术,有些患者甚至在儿童时期就进行了手术。结论:在我们的马凡综合征专门诊所对儿童进行 HTAD 评估可获得较高的诊断率,并具有后续的治疗意义。实际上,早期识别症状和体征并将其转介至专门诊所可能会导致早期诊断、监测和及时治疗,从而可能限制急性主动脉事件甚至死亡的发生。